NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘Mononuclear Bone Marrow Cells’

RSS

January 6th, 2014

Selections from Richard Lehman’s Literature Review: January 6th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the NAVIGATOR study, trials of stents, mitral valve repair vs. replacement, and more.

Categories: General
Tags: atherosclerotic renal-artery stenosis, beta-blockers, cardiac arrest, cardiopulmonary resuscitation, COPD, defibrillation, diabetes, diuretics, hypothermia, impaired glucose tolerance, Ischemic cardiomyopathy, left ventricular assist device thrombosis, mechanical chest compressions, medical therapy, mitral repair, mitral replacement, Mononuclear Bone Marrow Cells, severe ischemic mitral regurgitation, stents, Transendocardial Mesenchymal Stem Cells


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Intention to Treat — Season 2: The Race Equation: BiDil — The Story of the Black Pill — ITT Episode 2.5 June 4, 2026
      How did a drug for congestive heart failure get approved and marketed for Black people only?
    • Left Atrial Appendage Closure — Should Recommendations Be Expanded? June 4, 2026
      Owing to the fact that most thromboembolic complications that are attributed to atrial fibrillation originate in the left atrial appendage,1 therapies targeting the anatomical structure that might spare systemic harms are theoretically attractive. Randomized trials of left atrial appendage closure previously garnered an American College of Cardiology–American Heart...
    • Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation June 4, 2026
      In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding.
    • Emerging Era for Polymyalgia Rheumatica and GCA — Interleukin-17A Targeting June 3, 2026
      Since Dr. Phillip Hench reported on the efficacy of glucocorticoids for rheumatoid arthritis in 1949, glucocorticoids have saved many lives and have offered relief to countless patients. Glucocorticoids have been used as the mainstay of treatment for many immune-mediated inflammatory diseases, including polymyalgia rheumatica and giant-cell arteritis (GCA), owing to...
    • Science behind the Study: Remuscularizing the Failing Human Heart May 28, 2026
      The author describes the scientific foundations of a phase 1–2 study of stem-cell–derived ventricular assist tissue transplanted onto the epicardial surface of failing human hearts.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |